Ocular Therapeutix
Karen-Leigh Edwards joined Ocular Therapeutix in September 2021. Her career expertise includes senior global leadership roles in Product Development, Manufacturing & Operations and Business Development. Karen-Leigh is well-positioned to translate corporate vision into executable strategies to deliver marketable products and transform lives. Prior to Ocular, Karen-Leigh held a variety of positions at Alexion, Biogen and International Partnership for Microbicides.
She holds a Ph.D. degree in Chemistry from the University of Kansas and an MBA from the Massachusetts Institute of Technology. Karen-Leigh also earned a BSc degree in Chemistry from the University of the West Indies and an MSc degree in Chemistry from the University of London.
This person is not in any teams
This person is not in any offices
Ocular Therapeutix
2 followers
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology. The Company's bioresorbable hydrogel ba...